Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ARS Pharmaceuticals Inc
Swot
ARS Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ARS Pharmaceuticals Inc has 18 Strengths, 4 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(18)
Weakness
(4)
Opportunity
(0)
Threats
(2)
Others
(1)
Positive Breakout Third Resistance ( LTP > R3)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over the Quarter (3 Months)
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Company with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Stock gained more than 20% in one month
Positive Breakout (LTP > R1)
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Declining profits every quarter for the past 3 quarters
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
